Singapore, May 21 -- Vietnam headquartered Gene Solutions has introduced SPOT-MAS Lung, a next-generation blood-based test powered by artificial intelligence (AI) and multi-omics analysis.

Designed with lung-specific features, SPOT-MAS Lung may offer a promising approach for earlier detection in Asia, especially among asymptomatic individuals who are often missed by traditional screening, or patients with symptoms but inconclusive imaging results.

Asia bears the highest disease burden of lung cancer, accounting for 62% of global lung cancer deaths. Alarmingly, nearly 50% of patients in the region are diagnosed at the metastatic stage, when symptoms appear, and curative treatment is often no longer possible. When detected early, however,...